Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials


PTI, Nov 16, 2020, 4:10 PM IST

New Delhi: Covid-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman and Managing Director, Bharat Biotech said on Monday.

Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for Covid-19 which would be in the form of nasal drops and can be ready by next year.

“We partnered with ICMR for Covid-19 vaccine as we speak it entered the phase 3 trials,” he said.

Bharat Biotech is the only vaccine company in the world which has BSL3 production facility (Biosafety level 3), he said.

Last month the vaccine maker said it had successfully completed interim analysis of Phase I and II trials of the vaccine and is initiating Phase-III trials in 26,000 participants.

Covaxinis being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).

The city-based vaccine maker had on October 2 sought the Drug Controller General of India’s (DCGI) permission to conduct phase 3 randomised double-blind placebo-controlled multicentre trial of its Covid-19 vaccine, sources said.

“We are working on another vaccine through nasal drops my feeling is by next year it will reach the population,” Ella said.

Bharat Biotech in September said it entered into a licensing agreement with Washington University School of Medicine in St. Louis for a novel “chimp-adenovirus” (Chimpanzee adenovirus), single-dose intranasal vaccine for Covid-19.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Gunmen kill Pakistani policeman guarding polio workers

MP home minister directs DGP to file FIR against Amazon officials, owner

HC proposes to reduce costs on Juhi Chawla from Rs 20L to Rs 2L in 5G lawsuit

2007 obscenity case: Mumbai court calls Shilpa Shetty ‘victim’ of Richard Gere’s act, discharges her

86 pc Indians want voting to be made compulsory: Survey

No discontent on appointment of district in-charge Ministers: K’taka CM

Congress leader RPN Singh resigns from party


Related Articles More

Low-cost smartphone-based test can accurately detect COVID-19 in 20 minutes

Don’t want people’s livelihood to be affected, Covid curbs to be eased as soon as possible: Kejriwal

Shocking! Woman vaccinated four months after her death

Breakthrough COVID-19 infections generate strong antibody response: Study

Karnataka reports over 50,000 COVID-19 cases

MUST WATCH

Udupi’s Gangadhar Kadekar sets new record by swimming

The Death of the Indian Farmer: India’s Suicide Crisis

Gas Tanker Over Turns at Kumta

Dog saves baby deer from drowing into the water

2 Health Workers Fight Over Rs 500 In Bihar


Latest Additions

Jamaat-e-Islami Hind asks Muslim students not to participate in ‘Surya Namaskar’ on R-Day

EC ban on physical electioneering affects campaign material business

Mumbai records AQI 271; air quality severe in parts of city

HMSI launches 2022 CBR 650R at Rs 9.35 lakh

Fly-past of 75 aircraft, display of 10 scrolls to happen for first time at RDay parade: MoD

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.